| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/25/2008 | US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/25/2008 | US20080319050 Preparation Containing Oxidized Flavonoid Derivatives |
| 12/25/2008 | US20080319040 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents |
| 12/25/2008 | US20080319033 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma |
| 12/25/2008 | US20080319031 Novel Tyrosine Derivatives |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080319007 Deuterium-enriched montelukast |
| 12/25/2008 | US20080318955 4-[5-(1,1,2-Trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalen-4-yl)-[1,2,4]oxadiazol-3-yl]-phenol; G protein-coupled receptor S1P1/EDG1 (endothelial differentiation gene); new immunosuppressant; side effect reduction; transplant rejection; autoimmune diseases; antiinflammatory agents |
| 12/25/2008 | US20080318946 Di-amino-substituted heterocyclic compounds and methods of use |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318942 Fredericamycin Derivatives |
| 12/25/2008 | US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta |
| 12/25/2008 | US20080318917 Polyethylene glycolated superoxide dismutase mimetics |
| 12/25/2008 | US20080318916 Novel alpha glucosidase inhibitors from lichens |
| 12/25/2008 | US20080318911 20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080318906 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| 12/25/2008 | US20080318864 Methods and compositions regarding polychalcogenide compositions |
| 12/25/2008 | US20080318858 comprises a modified amino acid sequence comprising one or more amino acid substitutions to an amino acid sequence; substitutions are selected from the group consisting of H98Y, E102K, E108K, E120K; use as complement inhibitor |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/25/2008 | US20080318313 Method to Prevent Graft Rejection Using TGF-Beta to Induce T Suppressor Cells |
| 12/25/2008 | US20080318293 Sulfotransferase Inhibitors |
| 12/25/2008 | US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 12/25/2008 | US20080317878 Herbal Therapy for the Treatment of Food Allergy |
| 12/25/2008 | US20080317875 Inhibitor of PI3 kinase-dependent inflammatory cytokine synthesis and method for inhibiting the same |
| 12/25/2008 | US20080317868 Composition for improving membrane composition and functioning cells |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/25/2008 | US20080317809 Use of K -252a and Kinase Inhibitors for the Prevention or Treatment of Hmgb1-Associated Pathologies |
| 12/25/2008 | US20080317781 protecting non-wounded fish against coldwater disease caused by non-attenuated Flavobacterium psychrophilum comprising adminstering the fish by mass immersion an amount of an isolated, live attenuated, rifampicin-resistant Flavobacterium psychrophilum |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317756 Antibodies to Chemokine Alpha-5 |
| 12/25/2008 | US20080317751 Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317669 Cloning of honey bee allergen C |
| 12/24/2008 | WO2008157575A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | WO2008157210A1 Compounds and compositions as itpkb inhibitors |
| 12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155396A1 Method for testing a subject thought to have or to be predisposed to asthma |
| 12/24/2008 | WO2008155141A2 Novel facultative catonic sterols |
| 12/24/2008 | WO2008154868A1 Capsid proteins and uses therefore |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008154719A1 Recombinant human interferon-like proteins |
| 12/24/2008 | WO2008134659A3 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 12/24/2008 | EP2006687A1 Method of testing a subject thought to have or be predisposed to having asthma, allergie, atopic disease or atopic sensitization |
| 12/24/2008 | EP2005171A2 Inflammation-inhibitory serum factors and uses thereof |
| 12/24/2008 | EP2004692A1 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/24/2008 | EP2004649A2 Phenolic hydrazone macrophage migration inhibitory factor inhibitors |
| 12/24/2008 | EP2004631A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases |
| 12/24/2008 | EP2004626A2 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses |
| 12/24/2008 | EP2004621A2 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
| 12/24/2008 | EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 12/24/2008 | EP2004178A1 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders |
| 12/24/2008 | EP2004159A1 Autoimmune conditions and nadph oxidase defects |
| 12/24/2008 | EP1603555B1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/24/2008 | EP1549340B1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 12/24/2008 | EP1461306B1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | CN101331230A Methods and compositions for treating immune disorders |
| 12/24/2008 | CN101331229A Immunostimulatory oligoribonucleotides |
| 12/24/2008 | CN101331150A Human monoclonal antibody human CD134 (OX40) and methods of making and using same |
| 12/24/2008 | CN101330922A Treatment of hypersensitivity |
| 12/24/2008 | CN101330916A Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
| 12/24/2008 | CN101330835A Nutritional formulations containing octenyl succinate anahydride-modified tapioca starch |
| 12/24/2008 | CN101328166A 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor |
| 12/24/2008 | CN101327324A Method and composition for treating autoimmunity disease |
| 12/24/2008 | CN101327319A Use of DNA enzyme as medicament and preparation |
| 12/24/2008 | CN101327315A Use of maltose binding protein as immunopotentiator |
| 12/24/2008 | CN101327268A Oral chinese medicine for treating solar urticaria |
| 12/24/2008 | CN101327237A Composition containing plant effective component and preparation method and use thereof |
| 12/24/2008 | CN101327218A Immunoregulation novel use of cinobufagin |
| 12/24/2008 | CN101327209A Dihydromyricetin injection, powder injection and preparation method thereof |
| 12/24/2008 | CN101327201A Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 12/24/2008 | CN101327184A Solid preparation containing diphenhydramine |
| 12/24/2008 | CN101327179A Medicinal cosmetics for treating acne and scar thereof with antianaphylaxis function |
| 12/24/2008 | CN101326943A Bag tea for improving immunity |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100444841C Externally used loratadine formulation |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof |
| 12/24/2008 | CA2691100A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
| 12/24/2008 | CA2690668A1 Vaccines containing canine parvovirus genetic variants |
| 12/24/2008 | CA2688487A1 Compounds and compositions as itpkb inhibitors |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468181 Means and methods for the production of adenovirus vectors |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |